To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The development process for the ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The development process for the ...
Sempresto, Inc., a medical device company pioneering smartphone integrated rescue drug delivery, today announced the acquisition of Alerje’s mobile device integrated auto-injector platform, including ...
Please provide your email address to receive an email when new articles are posted on . Feasibility and acceptability scores for the autoinjector were highest among health care professionals. All ...
MannKind Corporation delivered strong Q3 '25 results, beating EPS and revenue estimates, and shares have responded positively. The FDA accepted the supplemental New Drug Application for the FUROSCIX ...
(RTTNews) - MannKind Corp.'s (MNKD) supplemental new drug application of FUROSCIX ReadyFlow Autoinjector for the treatment of edema in adults with chronic heart failure or chronic kidney disease has ...
Prior to initiating Brekiya, a cardiovascular evaluation is recommended. Brekiya ®, a ready-to-use dihydroergotamine (DHE) autoinjector, is now available for the acute treatment of migraine with or ...
A new study shows that a TXA autoinjector delivers lifesaving treatment for severe bleeding as effectively as traditional IV methods — but in under five minutes and without the need for medical ...
The US Food and Drug Administration (FDA) has approved a new version of an Alzheimer’s disease drug that can be given as a quick at-home weekly injection, offering patients a far more convenient ...
"This is a platform that potentially works with any biologic drug, so that we can inject it easily," says Appel. "That takes these treatments from a several-hour ordeal at a clinic with an IV infusion ...
On Thursday, the U.S. Food and Drug Administration (FDA) approved Ionis Pharmaceuticals, Inc.’s (NASDAQ:IONS) Dawnzera (donidalorsen) for prophylaxis to prevent attacks of hereditary angioedema (HAE) ...